BCLI
BRAINSTORM CELL THERAPUTC
BCLI
BCLI
Delisted
BCLI was delisted on the 17th of July, 2025.
75 hedge funds and large institutions have $32.1M invested in BRAINSTORM CELL THERAPUTC in 2021 Q1 according to their latest regulatory filings, with 11 funds opening new positions, 24 increasing their positions, 23 reducing their positions, and 26 closing their positions.
Holders
75
Holders Change
-15
Holders Change %
-16.67%
% of All Funds
1.32%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
11
Increased
24
Reduced
23
Closed
26
Calls
$3.17M
Puts
$4.87M
Net Calls
-$1.7M
Net Calls Change
-$1.03M
Top Buyers
1 |
![]()
1
JPMorgan Chase & Co
New York
|
$3.09M |
2 |
IC
2
Ikarian Capital
Dallas,
Texas
|
$1.12M |
3 |
SM
3
Sabby Management
Miami Beach,
Florida
|
$523K |
4 |
4
Two Sigma Advisers
New York
|
$461K |
5 |
5
T. Rowe Price Associates
Baltimore,
Maryland
|
$468K |